| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000017601 |
| Receipt No. | R000020239 |
| Official scientific title of the study | Change of blood sugar level under the influence of anesthetics |
| Date of disclosure of the study information | 2015/05/18 |
| Last modified on | 2016/05/18 (Ver. 3) |
| Basic information | ||
| Official scientific title of the study | Change of blood sugar level under the influence of anesthetics | |
| Title of the study (Brief title) | Change of blood sugar level under the influence of anesthetics | |
| Region |
|
|
| Condition | ||
| Condition | breast canser | |
| Classification by specialty |
|
|
| Classification by malignancy | Malignancy | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | To examine a change of the blood sugar level after the sugar load by the difference of the anesthetic |
| Basic objectives2 | Pharmacokinetics |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | Change of blood sjgar or insulin level |
| Key secondary outcomes | |
| In outcomes field, the entry of just a few words such as "safety" or "efficiency" will not be accepted. Specify the name of outcome measures, including the time when you plan to measure. Usually, only one primary outcome is accepted. Write the other outcomes in "secondary outcomes" field. |
| Base | |
| Study type | Observational |
| Study design | |
| Basic design | |
| Randomization | |
| Randomization unit | |
| Blinding | |
| Control | |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | |
| No. of arms | |
| Purpose of intervention | |
| Type of intervention | |
| Interventions/Control_1 | |
| Interventions/Control_2 | |
| Interventions/Control_3 | |
| Interventions/Control_4 | |
| Interventions/Control_5 | |
| Interventions/Control_6 | |
| Interventions/Control_7 | |
| Interventions/Control_8 | |
| Interventions/Control_9 | |
| Interventions/Control_10 | |
| In interventions field, include the details of interventions, such as duration, amount, and frequency. If the intervention includes prescription or use of medical devices, duration is required. |
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Female | |||
| Key inclusion criteria | ASA-1
Woman Patient without complications and receive a breast cancer operation in our Hospital |
|||
| Key exclusion criteria | There are complications
An agreement is not provided |
|||
| Target sample size | 100 | |||
| Research contact person | |
| Name of lead principal investigator | Arisa Iwakura |
| Organization | Gifu University School of Medicine |
| Division name | Department of Anesthesiology and Critical Care Medicine |
| Address | 1-1 Yanagido Gihu-City |
| TEL | 058-230-6404 |
| ars_i_0802@yahoo.co.jp | |
| Public contact | |
| Name of contact person | Iwakura Arisa |
| Organization | Gifu University School of Medicine |
| Division name | Department of Anesthesiology and Critical Care Medicine |
| Address | 1-1 Yanagido Gihu-City |
| TEL | 058-230-6404 |
| Homepage URL | |
| ars_i_0802@yahoo.co.jp | |
| Sponsor | |
| Institute | Gifu University Hospital |
| Institute | |
| Department | |
| Sponsor means an organization that is responsible for plan, deployment and report of the research including funding management. It doesn't mean funding agency". Therefore, all clinical trial should have the one. |
| Funding Source | |
| Organization | Gifu University School of Medicine |
| Organization | |
| Division | |
| Category of Funding Organization | Other |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date | |||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Partially published |
| URL releasing results | |
| Results | |
| Other related information | Examine blood sugar level after having performed sugar load by general anesthesia, the change of the insulin level. |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000020239 |